Piaopiao Li, M.S.

Piaopiao Li headshot

Contact Information

Email: piaopiao.li@ufl.edu

Curriculum Vitae

Education

  • 2020-present Ph.D. candidate, Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Florida, USA
  • 2016-2018 M.S., Pharmaceutics, Peking University, Beijing, China                                           
  • 2012-2016 B.S.,  Pharmacy, Peking University, Beijing, China

Entry Date into the POP Ph.D. program: Fall, 2020

Research Interests

Diabetes, Disease Progression Modeling/Simulation, Health Economics and Outcomes Research

Professional Experience

  • Jul.2018-Jun.2019, Johnson & Johnson, Janssen China Research&Development, Department of Clinical Operation, Site Manager, Shanghai, China   
  • Nov.2017-Jan.2018, Taikang Life Insurance co., ltd, Intern, Beijing, China
  • Sep.2017-Jan.2018, School of Pharmaceutical Science, Peking University, Teaching assistant of Pharmacotherapeutics, Beijing, China           

Publications

  • Li PP, Yan Y, Zhang HT, et al. Biological activities of siRNA-loaded lanthanum phosphate nanoparticles on colorectal cancer. J Control Release. 2020;328:45-58. 
  • Piaopiao Li1, Yi Yan,Haitao Zhang,Ru Wang,Huhu Han,Jiancheng Wang*, Treatment of cervical cancer by siRNA-loadedchitosan-coated calcium phosphate nanoparticles. Journal of Chinese Pharmaceutical Sciences, 2018, 27(8): 517-529.
  • Weizhong Liu1, Piaopiao Li2, Jiancheng Wang*,Comparison of in vitro effects of PCL-R15/siRNA nanoparticles prepared by different methods. Chinese Journal of New Drugs, 2017(52):2006.